Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy

Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy

We examined whether hepatitis C virus (HCV) genotype 1b core- and NS5A-region mutations are associated with response to peginterferon α-2b plus ribavirin combination therapy. A total of 103 patients with high HCV genotype 1b viral loads (≥100 KIU/mL) were treated with the combination therapy. Pretre...

Full description

Bibliographic Details
Main Authors:	Nakamoto, Shingo, Imazeki, Fumio, Arai, Makoto, Yasui, Shin, Nakamura, Masato, Haga, Yuki, Sasaki, Reina, Kanda, Tatsuo, Shirasawa, Hiroshi, Yokosuka, Osamu
Format:	Online
Language:	English
Published:	MDPI 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613248/

Similar Items

Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin
by: Kanda, Tatsuo, et al.
Published: (2016)

Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype
by: Kanda, Tatsuo, et al.
Published: (2015)

Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin
by: Miyamura, Tatsuo, et al.
Published: (2012)

Alanine Aminotransferase Elevation during Peginterferon Alpha-2a or Alpha-2b plus Ribavirin Treatment
by: Nakamura, Masato, et al.
Published: (2013)

Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan
by: Kanda, Tatsuo, et al.
Published: (2016)

Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy
by: Kanda, Tatsuo, et al.
Published: (2012)

Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy
by: Tatsuo Kanda, Shingo Nakamoto, Takayoshi Nishino, Nobuo Takada, Akihito Tsubota, Keizo Kato, Tatsuo Miyamura, Daisuke Maruoka, Shuang Wu, Takeshi Tanaka, Makoto Arai, Shigeru Mikami, Keiichi Fujiwara, Fumio Imazeki, Osamu Yokosuka
Published: (2013-01-01)

Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells
by: Sasaki, Reina, et al.
Published: (2016)

Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report
by: Ohta, Yuki, et al.
Published: (2016)

Recent Trend of Hepatitis E Virus Infection in Chiba Area, Japan: 3 of 5 Cases with Rheumatoid Arthritis
by: Kanda, Tatsuo, et al.
Published: (2015)

Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin
by: Sasaki, Reina, et al.
Published: (2016)

Acute Liver Injury in a Patient with Alcohol Dependence: A Case Resembling Autoimmune Hepatitis or Drug-Induced Liver Injury
by: Hayashi, Masahiro, et al.
Published: (2014)

Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected Patients
by: Kanda, Tatsuo, et al.
Published: (2014)

MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells
by: Nakamura, Masato, et al.
Published: (2015)

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
by: Kanda, Tatsuo, et al.
Published: (2015)

Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation
by: Jiang, Xia, et al.
Published: (2015)

Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB
by: Wu, Shuang, et al.
Published: (2016)

Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation
by: Sasaki, Reina, et al.
Published: (2016)

IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens
by: Miyamura, Tatsuo, et al.
Published: (2014)

Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients
by: Miyamura, Tatsuo, et al.
Published: (2011)

Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress
by: JIANG, XIA, et al.
Published: (2014)

Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
by: Kanda, Tatsuo, et al.
Published: (2011)

Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
by: Tatsuo Kanda, Masami Shinozaki, Hidehiro Kamezaki, Shuang Wu, Shingo Nakamoto, Makoto Arai, Keiichi Fujiwara, Nobuaki Goto, Fumio Imazeki, Osamu Yokosuka
Published: (2012-01-01)

Acute Liver Failure Associated with Propylthiouracil in a Pregnant 26-Year-Old Woman
by: Miyamura, Tatsuo, et al.
Published: (2013)

Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
by: T Kanda, et al.
Published: (2011-03-01)

Adherence to Medication Is a More Important Contributor to Viral Breakthrough in Chronic Hepatitis B Patients Treated with Entecavir Than in Those with Lamivudine
by: Kamezaki, Hidehiro, et al.
Published: (2013)

Factors Associated with Inadequate Tissue Yield in EUS-FNA for Gastric SMT
by: Suzuki, Takuto, et al.
Published: (2011)

Hepatitis C Virus Nonstructural Protein 5A Inhibits Thapsigargin-Induced Apoptosis
by: Jiang, Xia, et al.
Published: (2014)

Efficacy of Lamivudine or Entecavir against Virological Rebound after Achieving HBV DNA Negativity in Chronic Hepatitis B Patients
by: Miyauchi, Tomoo, et al.
Published: (2013)

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
by: Kanda, Tatsuo, et al.
Published: (2014)

Successful Management of Acute Liver Failure Patients Waiting for Liver Transplantation by On-Line Hemodiafiltration with an Arteriovenous Fistula
by: Haga, Yuki, et al.
Published: (2016)

No Correlation between PNPLA3 rs738409 Genotype and Fatty Liver and Hepatic Cirrhosis in Japanese Patients with HCV
by: Nakamura, Masato, et al.
Published: (2013)

Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
by: Kanda, Tatsuo, et al.
Published: (2014)

Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response
by: Etoh, Reiko, et al.
Published: (2011)

A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection
by: Xiao, Nan, et al.
Published: (2010)

18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis
by: Tawada, Akinobu, et al.
Published: (2014)

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
by: Kim, Yu Jin, et al.
Published: (2011)

Increased Baseline Proinflammatory Cytokine Production in Chronic Hepatitis C Patients with Rapid Virological Response to Peginterferon Plus Ribavirin
by: Par, Gabriella, et al.
Published: (2013)

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
by: Heo, Nae-Yun, et al.
Published: (2013)

Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
by: Yu, Ming-Lung, et al.
Published: (2012)